Aadi Bioscience (AADI) Competitors $1.97 +0.02 (+1.03%) As of 09/18/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock AADI vs. TNYA, SLS, MDWD, EPRX, CCCC, DERM, AARD, BDTX, IPHA, and SCLXShould you be buying Aadi Bioscience stock or one of its competitors? The main competitors of Aadi Bioscience include Tenaya Therapeutics (TNYA), SELLAS Life Sciences Group (SLS), MediWound (MDWD), Eupraxia Pharmaceuticals (EPRX), C4 Therapeutics (CCCC), Journey Medical (DERM), Aardvark Therapeutics (AARD), Black Diamond Therapeutics (BDTX), Innate Pharma (IPHA), and Scilex (SCLX). These companies are all part of the "pharmaceutical products" industry. Aadi Bioscience vs. Its Competitors Tenaya Therapeutics SELLAS Life Sciences Group MediWound Eupraxia Pharmaceuticals C4 Therapeutics Journey Medical Aardvark Therapeutics Black Diamond Therapeutics Innate Pharma Scilex Aadi Bioscience (NASDAQ:AADI) and Tenaya Therapeutics (NASDAQ:TNYA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability. Do analysts prefer AADI or TNYA? Tenaya Therapeutics has a consensus price target of $6.25, suggesting a potential upside of 343.26%. Given Tenaya Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Tenaya Therapeutics is more favorable than Aadi Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aadi Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Tenaya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, AADI or TNYA? Aadi Bioscience has higher revenue and earnings than Tenaya Therapeutics. Tenaya Therapeutics is trading at a lower price-to-earnings ratio than Aadi Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAadi Bioscience$25.07M1.94-$65.76M-$2.35-0.84Tenaya TherapeuticsN/AN/A-$111.13M-$0.96-1.47 Does the media refer more to AADI or TNYA? In the previous week, Tenaya Therapeutics had 1 more articles in the media than Aadi Bioscience. MarketBeat recorded 1 mentions for Tenaya Therapeutics and 0 mentions for Aadi Bioscience. Aadi Bioscience's average media sentiment score of 0.00 equaled Tenaya Therapeutics'average media sentiment score. Company Overall Sentiment Aadi Bioscience Neutral Tenaya Therapeutics Neutral Do insiders & institutionals hold more shares of AADI or TNYA? 52.1% of Aadi Bioscience shares are owned by institutional investors. Comparatively, 90.5% of Tenaya Therapeutics shares are owned by institutional investors. 37.3% of Aadi Bioscience shares are owned by company insiders. Comparatively, 48.7% of Tenaya Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is AADI or TNYA more profitable? Tenaya Therapeutics has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Tenaya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aadi Bioscience-246.06% -71.87% -57.28% Tenaya Therapeutics N/A -93.83%-75.66% Which has more risk and volatility, AADI or TNYA? Aadi Bioscience has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Tenaya Therapeutics has a beta of 3.07, suggesting that its share price is 207% more volatile than the S&P 500. SummaryTenaya Therapeutics beats Aadi Bioscience on 9 of the 14 factors compared between the two stocks. Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AADI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AADI vs. The Competition Export to ExcelMetricAadi BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.65M$858.70M$5.79B$10.40BDividend YieldN/A4.84%5.63%4.60%P/E Ratio-0.861.2176.4826.75Price / Sales1.9426.44531.95124.23Price / CashN/A19.5637.9261.55Price / Book0.466.7013.726.40Net Income-$65.76M-$4.03M$3.29B$271.62M7 Day Performance-1.99%-1.56%1.03%2.85%1 Month Performance22.36%10.27%6.32%9.64%1 Year Performance7.65%19.97%81.16%31.62% Aadi Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AADIAadi BioscienceN/A$1.97+1.0%N/A+4.3%$48.65M$25.07M-0.8640Gap DownTNYATenaya Therapeutics2.2971 of 5 stars$1.20flat$6.25+420.8%-34.7%$195.57MN/A-1.25110SLSSELLAS Life Sciences Group1.1491 of 5 stars$1.68-9.2%$7.00+316.7%+32.0%$194.80M$1M-5.2510MDWDMediWound1.5439 of 5 stars$17.14-3.9%$32.25+88.2%-1.8%$192.81M$20.22M-6.4980Positive NewsEPRXEupraxia Pharmaceuticals2.2499 of 5 stars$5.30-0.4%$11.00+107.5%+113.4%$191.13MN/A-6.2429Positive NewsCCCCC4 Therapeutics3.0996 of 5 stars$3.57+34.2%$8.67+142.8%-48.0%$189.31M$35.58M-2.26150News CoverageAnalyst ForecastGap UpHigh Trading VolumeDERMJourney Medical2.1754 of 5 stars$7.12+0.1%$12.17+70.9%+42.0%$187.06M$56.40M-18.7490Positive NewsAARDAardvark Therapeutics3.7056 of 5 stars$9.95+15.8%$32.60+227.6%N/A$186.38MN/A0.0018Positive NewsGap UpHigh Trading VolumeBDTXBlack Diamond Therapeutics3.3879 of 5 stars$3.19-1.8%$11.67+265.7%-29.2%$185.04M$70M13.8790IPHAInnate Pharma2.5431 of 5 stars$2.07+3.3%$11.00+432.7%-13.8%$184.37M$21.77M0.00220News CoverageAnalyst DowngradeGap UpSCLXScilex2.3694 of 5 stars$25.70-2.2%$455.00+1,670.4%-27.4%$182.80M$56.59M-0.8980Positive NewsGap Up Related Companies and Tools Related Companies TNYA Competitors SLS Competitors MDWD Competitors EPRX Competitors CCCC Competitors DERM Competitors AARD Competitors BDTX Competitors IPHA Competitors SCLX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AADI) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
